Aether Industri. Q2 FY27 Earnings Call — Analysis (NSE: AETHER)
Aether reported robust traction in contract exclusive manufacturing (CEM) and CRAMS, reaching over 65% of sales, while securing expanded contracts with Baker Hughes and advancing commercialisation across its 16-block Site Magnum.
Result quality: stable — Results context unavailable. Management sentiment: optimistic.
The take
Q2FY27 CRAMS and CEM Sales Contribution 65% . New guidance — FY29 semiconductor revenue target ₹300 Cr to ₹400 Cr . New story: Site Magnum Multi-Block Commercialisation .
Results
CRAMS and CEM contributed >65% of sales while Oil & Gas reached 33%, with working capital at 165 days and ₹700 Cr in CWIP.
Financial highlights
| Metric | Value | Change | Basis |
|---|---|---|---|
| CRAMS and CEM Sales Contribution | 65% | none · Q2FY27 · share of total sales | |
| Oil & Gas Sales Contribution | 33% | none · Q2FY27 · share of total sales | |
| Working Capital Cycle | 165 days | +3 days | sequential · Q2FY27 · vs 31-Mar-2026 |
| Inventory Days | 172 days | +21 days | sequential · Q2FY27 · vs 151 days at 31-Mar-2026 |
| Capital Work-in-Progress | ₹700 Cr | point_in_time · Q2FY27 · as of Sep-2026 | |
| FY27 Capex Guidance | ₹350 Cr to ₹370 Cr | none · FY27 · full year guidance |
Guidance
Management guided FY27 capex at ₹350-370 Cr, with ~₹400 Cr of CWIP expected to capitalise by end-FY27 and semiconductor revenues targeting ₹300-400 Cr by FY29.
What management committed to
- [Aether Industries] will commercialise commercial production from the dedicated semiconductor block at [Magnum Site] from quarter 4 of financial year 2027. — Q4FY27
- [Aether Industries] will begin commercial production of the new agrochemical innovator CEM contract at [Magnum Block 4] in Q4 FY27 at 200 to 250 tons per year ramping to around 600 tons per year. — 200 to 250 tons per year, Q4FY27
- [Aether Industries] expects total FY27 capex to be between [₹350 crores and ₹370 crores]. — INR350 crores to INR370 crores, FY27
- [Aether Industries] expects approximately [₹400 crores] of CWIP to be capitalised into gross block by the end of [FY27]. — INR400 crores, FY27
- [Aether Industries] targets [₹300 crores to ₹400 crores] of top line from the semiconductor business by [FY29] (300 to 400 tons volume at USD 45 to USD 50 per kg). — INR300 crores to INR400 crores, FY29
- [Aether Industries] plans to launch a minimum of [2 products] on the LSM side every year. — 2 products, every year minimum
- [Aether Industries] will not take up hazardous chemistries including [HF, F2, and H2S].
Key themes
CEM transition and Site Magnum scale-up
How the narrative shifted
- Site Magnum Multi-Block Commercialisation: Management is rapidly building out Site Magnum with clear line of sight on 14 of 16 blocks primarily dedicated to high-margin CEM contracts.
- High-Tech Product Diversification (Semiconductor & Silicones): Expanding aggressively beyond traditional pharma/agro into high-value semiconductor building blocks and the Dow continuous-flow silicones research platform.
- Oil & Gas Anchor Expansion: Scaling strategic partnership with Baker Hughes through new product streams at Site 4 targeting >$100M revenue over time.
- Working Capital and Inventory Buffering: Elevated working capital and 172 inventory days are framed as deliberate raw material stocking for US/Far East import lead times on long-term pass-through CEM contracts.
Operational commentary
- Commercialised a new set of oilfield industrial chemicals for Baker Hughes in Q2FY27 following minor modifications at Strata (Site 4), doubling Baker Hughes market opportunity to ₹750-800 Cr with long-term target of >$100 million (>₹1,000 Cr).
- Initiated first commercial shipments of semiconductor chemicals from existing facilities; dedicated Magnum production block on track for Q4FY27 commercialisation targeting ₹300-400 Cr sales by FY29 (300-400 tons @ $45-50/kg).
- Signed new CEM contract with a leading global agrochemical innovator for a patented NCE advanced intermediate; commercial production at Magnum Block 4 starting Q4FY27 (200-250 TPA initial, scaling to ~600 TPA).
- Achieved line of sight on 14 of 16 production blocks at Magnum (2 LSM, 12 CEM), with 6+ blocks above ground and major civil construction progressing ahead of schedule.
- Transitioned R&D operations from 24/6 to 24/7 to accelerate project turnaround; active pipeline exceeds 65 CRAMS projects.
- Added 16 new customers and completed over 20 customer/certification audits in H1FY27.
Analyst Q&A
Q. What is the weighted average borrowing cost and how much interest was capitalised in H1FY27?
Declined to disclose the interest rate on a public call, stating loan capitalisation covers ₹200 Cr of debt and offered to connect offline.
Q. Will FY27-28 capex exceed the guided ₹300-350 Cr given rapid construction at Magnum and R&D expansions?
Civil works for first 8 blocks are largely complete; equipment orders are phased to match start dates, keeping FY27 capex within ₹350-370 Cr.
Q. Why have inventory days increased from 151 to 172 days in H1FY27?
Explained inventory build-up as strategic buffer stock for raw materials imported from the US/Far East for new contracts (Milliken and Magnum launches) to prevent production disruptions, with cost pass-through terms in CEM contracts.
Research and educational content only. Not investment advice.